Related Experiment Videos
Clinical evaluation of moxalactam
Antimicrobial Agents and Chemotherapy
|July 1, 1981
Summary
Moxalactam demonstrated excellent clinical efficacy in treating diverse bacterial infections, including gram-negative bacillary diseases. The antibiotic showed high cure rates with minimal, non-severe adverse effects in 50 patients.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Bacterial infections pose significant therapeutic challenges.
- Novel antimicrobial agents are crucial for combating resistant pathogens.
- Moxalactam is a newer antibiotic with potential broad-spectrum activity.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of moxalactam.
- To assess moxalactam's effectiveness against various bacterial infections.
- To determine moxalactam's utility in treating gram-negative bacillary diseases.
Main Methods:
- A clinical study involving 50 patients with confirmed bacterial infections.
- Patients received moxalactam treatment for diverse infectious disorders.
- Efficacy assessed by clinical and bacteriological cure criteria.
Main Results:
- Moxalactam exhibited excellent overall efficacy.
- 48/50 patients achieved clinical cure; 45/50 achieved bacteriological cure.
- 18/50 patients experienced mild adverse reactions, with only one discontinuation.
Conclusions:
- Moxalactam is a highly effective antibiotic for various infections.
- It is particularly valuable for treating gram-negative bacillary infections.
- Moxalactam represents a significant therapeutic option with a favorable safety profile.